1. Home
  2. PACB vs RCS Comparison

PACB vs RCS Comparison

Compare PACB & RCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • RCS
  • Stock Information
  • Founded
  • PACB 2000
  • RCS 1994
  • Country
  • PACB United States
  • RCS United States
  • Employees
  • PACB N/A
  • RCS N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • RCS Investment Managers
  • Sector
  • PACB Industrials
  • RCS Finance
  • Exchange
  • PACB Nasdaq
  • RCS Nasdaq
  • Market Cap
  • PACB 381.5M
  • RCS 334.5M
  • IPO Year
  • PACB 2010
  • RCS N/A
  • Fundamental
  • Price
  • PACB $1.23
  • RCS $7.43
  • Analyst Decision
  • PACB Buy
  • RCS
  • Analyst Count
  • PACB 7
  • RCS 0
  • Target Price
  • PACB $1.90
  • RCS N/A
  • AVG Volume (30 Days)
  • PACB 5.1M
  • RCS 141.1K
  • Earning Date
  • PACB 11-06-2025
  • RCS 01-01-0001
  • Dividend Yield
  • PACB N/A
  • RCS 10.12%
  • EPS Growth
  • PACB N/A
  • RCS N/A
  • EPS
  • PACB N/A
  • RCS N/A
  • Revenue
  • PACB $156,110,000.00
  • RCS N/A
  • Revenue This Year
  • PACB $6.15
  • RCS N/A
  • Revenue Next Year
  • PACB $15.68
  • RCS N/A
  • P/E Ratio
  • PACB N/A
  • RCS N/A
  • Revenue Growth
  • PACB N/A
  • RCS N/A
  • 52 Week Low
  • PACB $0.85
  • RCS $4.51
  • 52 Week High
  • PACB $2.72
  • RCS $6.31
  • Technical
  • Relative Strength Index (RSI)
  • PACB 45.49
  • RCS 70.74
  • Support Level
  • PACB $1.15
  • RCS $7.30
  • Resistance Level
  • PACB $1.32
  • RCS $7.35
  • Average True Range (ATR)
  • PACB 0.07
  • RCS 0.05
  • MACD
  • PACB -0.00
  • RCS 0.01
  • Stochastic Oscillator
  • PACB 40.00
  • RCS 81.82

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About RCS PIMCO Strategic Income Fund Inc.

PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.

Share on Social Networks: